NeoGenomics NEO Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $2.24M+105% | -$17.11M+34.0% | -$9.88M+35.5% | -$27.13M-53.3% | -$45.09M-142% | ||
| $8.58M-6.2% | $8.78M-6.3% | $8.76M-10.8% | $8.8M-8.5% | $9.14M-6.2% | ||
| $8.22M-32.7% | $9.64M-10.4% | $8.04M-3.4% | $10.31M— | $12.21M+38.2% | ||
| $19.96M-1.8% | -$8.14M+67.9% | $1.34M-86.3% | $8.88M— | $20.33M— | ||
| $8.22M+30.0% | $5M+11.1% | $7.87M-32.1% | $8.31M-23.0% | $6.32M-51.7% | ||
| —— | —— | —— | $463K— | —— | ||
| -$8.32M+10.7% | -$5M-240% | -$6.31M— | -$277K— | -$9.31M-227% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $50.31M— | $50.31M— | $50.31M— | ||
| -$12.24M+94.0% | -$338K-136% | —— | —— | -$202.43M-10,397% | ||
| -$604K+99.7% | -$13.48M+35.3% | -$4.5M-190% | $0-100% | -$191.47M-926% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.0M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $29.4M of capital expenditures, NeoGenomics's free cash flow was -$7.4M over the trailing twelve months, up 86.5% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
